UPMC Hillman Cancer Center San Pietro FBF: 5,000 Cancer Patients Treated

Cutting-edge treatment pathways in the radiotherapy field that contribute to improving the quality of life of patients

5 thousand cancer patients treated, for a total of 56,500 radiotherapy sessions. This is the "goal" reached from January 2013, the year of the inauguration, to date by the UPMC Hillman Cancer Center San Pietro FBF High Specialization Radiotherapy Center in Rome. Structure that qualifies for services and services offered to patients of the latest generation, confirming the philosophy and objectives of UPMC (University of Pittsburgh Medical Center), a US academic medicine center with a turnover of 21 billion dollars. Of particular importance are the equipment for radiotherapy treatments, delivered with high-tech machinery and methods. Among these, stereotactic radiotherapy with which 60% of patients with excellent efficacy results have been treated. It is, in fact, an advanced therapy that allows you to irradiate with extreme precision even delicate tumors or in more difficult to reach locations, directing high doses of radiation directly on the tumor volume, while preserving as much as possible the surrounding healthy organs and tissues to the advantage of a significant reduction in side effects. In addition, stereotactic radiotherapy is concentrated in a few sessions compared to conventional radiotherapy, with an additional benefit for the patient in terms of time, management and psychological relapses. All treatments are also accessible with the National Health Service. The UPMC Hillman Cancer Center San Pietro FBF also stands out for being the first center in the Lazio Region to equip itself with advanced technology for the delivery of radiotherapy (Truebeam), now also available at the twin Villa Maria in Mirabella Eclano. Two facilities that are part of the international UPMC Hillman Cancer Center network that includes more than 60 cancer centers in the United States and Europe, able to ensure the highest standard of care for more than 113,000 patients each year. All cancer centers in the network are partners of the Pittsburgh University Cancer Institute.